Needham & Company LLC Reaffirms “Buy” Rating for Privia Health Group (NASDAQ:PRVA)

Privia Health Group (NASDAQ:PRVA)‘s stock had its “buy” rating restated by stock analysts at Needham & Company LLC in a report released on Friday,Benzinga reports. They currently have a $30.00 target price on the stock. Needham & Company LLC’s price target suggests a potential upside of 28.81% from the stock’s current price.

Several other research analysts also recently weighed in on the company. Stephens reiterated an “overweight” rating and set a $26.00 price target on shares of Privia Health Group in a research note on Thursday, January 2nd. Canaccord Genuity Group boosted their price target on shares of Privia Health Group from $29.00 to $30.00 and gave the company a “buy” rating in a research report on Friday, February 28th. JMP Securities set a $29.00 price objective on shares of Privia Health Group in a report on Friday, February 28th. JPMorgan Chase & Co. boosted their target price on shares of Privia Health Group from $27.00 to $28.00 and gave the company an “overweight” rating in a report on Friday, November 29th. Finally, Piper Sandler raised their price target on Privia Health Group from $25.00 to $40.00 and gave the stock an “overweight” rating in a report on Friday, February 28th. One analyst has rated the stock with a hold rating, thirteen have issued a buy rating and two have issued a strong buy rating to the company. Based on data from MarketBeat, Privia Health Group has a consensus rating of “Buy” and an average price target of $26.67.

Privia Health Group Trading Down 1.5 %

Privia Health Group stock opened at $23.29 on Friday. The business’s 50 day simple moving average is $23.59 and its 200 day simple moving average is $21.00. Privia Health Group has a 12 month low of $15.92 and a 12 month high of $26.04. The company has a market cap of $2.81 billion, a price-to-earnings ratio of 232.92, a PEG ratio of 3.47 and a beta of 0.85.

Institutional Trading of Privia Health Group

Several hedge funds and other institutional investors have recently bought and sold shares of the stock. First Horizon Advisors Inc. grew its holdings in shares of Privia Health Group by 53.8% in the fourth quarter. First Horizon Advisors Inc. now owns 1,807 shares of the company’s stock worth $35,000 after purchasing an additional 632 shares during the last quarter. EverSource Wealth Advisors LLC increased its position in shares of Privia Health Group by 7,833.3% in the fourth quarter. EverSource Wealth Advisors LLC now owns 2,380 shares of the company’s stock valued at $47,000 after acquiring an additional 2,350 shares during the period. Financial Management Professionals Inc. bought a new position in shares of Privia Health Group during the fourth quarter valued at about $51,000. Quarry LP boosted its holdings in shares of Privia Health Group by 344.6% during the third quarter. Quarry LP now owns 3,268 shares of the company’s stock worth $60,000 after purchasing an additional 2,533 shares during the period. Finally, KBC Group NV grew its stake in shares of Privia Health Group by 34.6% in the third quarter. KBC Group NV now owns 3,385 shares of the company’s stock worth $62,000 after purchasing an additional 871 shares during the last quarter. Institutional investors own 94.48% of the company’s stock.

Privia Health Group Company Profile

Privia Health Group, Inc operates as a national physician-enablement company in the United States. The company collaborates with medical groups, health plans, and health systems to optimize physician practices, enhance patient experiences, and reward doctors for delivering care in-person and virtual settings.